Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Tokio Takeuchi is active.

Publication


Featured researches published by Tokio Takeuchi.


Acta Haematologica | 1994

Primary Hodgkin's disease of the bone presenting with an extradural tumor

Kazuaki Moridaira; Hiroshi Handa; Hirokazu Murakami; Toshimasa Uchiyama; Tokio Takeuchi; Sadao Sato; Jun'ichi Tamura; Takuji Naruse; Jun Tsuchiya

We report a very rare case of primary Hodgkins disease of the bone in a 56-year-old male. It presented with sudden onset of paraparesis which suggested an extradural tumor. Early appropriate therapy for similar patients with Hodgkins disease can improve their prognosis.


Apmis | 2007

Primary cutaneous CD5+ marginal zone B-cell lymphoma resembling the plasma cell variant of Castleman's disease. Case report.

Norifumi Tsukamoto; Masaru Kojima; Toshimasa Uchiyama; Tokio Takeuchi; Masamitsu Karasawa; Hirokazu Murakami; Sadao Sato

Marginal zone B‐cell lymphoma (MZBL) is occasionally associated with prominent plasma cell differentiation. However, MZBL rarely exhibits histological features that resemble plasmacytoma arising from a localized plasma cell variant of Castlemans disease (PCCD). We here report a histologically similar case that was associated with primary cutaneous tumor. The patient was a 57‐year‐old woman with a 5‐year history of cutaneous nodules. Histologically, a prominent proliferation of plasma cells occupied the interfollicular area of the central portion of the cutaneous tumor, whereas various numbers of CD5+ centrocyte‐like (CCL) cells, which were arranged in a marginal zone distribution pattern, occupied the peripheral region of the tumor. The majority of the lymphoid follicles had atrophic or regressive germinal centers resembling hyaline‐vascular Castlemans disease. CCL cells were observed to have colonized a few of the lymphoid follicles. Immunohistochemistry revealed that these cells had a monotypic intracytoplasmic kappa chain. Without treatment, the patient was quiescent, but 2 years later, there was a transformation to the large cell type. These observations suggest that MZBL needs to be distinguished from PCCD, and that untreated cutaneous MZBL may undergo a high‐grade blastic transformation similar to other indolent lymphoproliferative disorders.


Thrombosis Research | 1976

Role of blood platelet in the formation of thrombus

Tadashi Maekawa; Norio Kobayashi; Hitoshi Arai; Tokio Takeuchi

Abstract In the busulfan-induced thrombocytopenic rabbits, the femoral artery was completely occluded after injection with ellagic acid at the site of stenosing ligature in 5 out of 15 rabbits, while in the control rabbits with normal platelet count, a large thrombus was present around the stricture in 12 out of 17 rabbits. Occluding thrombus was produced in only 2 out of 15 rabbits which ingested more than 0.05 g of aspirin 6 hours before surgery. Rate of occluding thrombus formation on the chemically intimectomized femoral artery with diluted sulfuric acid was evidently high in the rabbits with rebound thrombocytosis after transient thrombocytopenia induced by intravenous injection with anti-platelet serum. In the case of stasis thrombus formation, both in thrombocytopenic rabbits and in aspirin-ingested rabbits, percentage of rabbits producing the thrombus was not significantly different from that of the control. From the results described above, it is suggested that both quantitatively and qualitatively normal platelets are required for the production of arterial thrombosis. On the other hand, blood platelets may not contribute to the formation of stasis thrombosis.


Japanese Journal of Thrombosis and Hemostasis | 1980

The effect of aspirin on vascular prostaglandin I2 formation in rabbits

Norio Kobayashi; Masashi Takada; Hiroshi Tanaka; Shozo Tanaka; Tatsuo Ueno; Tokio Takeuchi; Hidemi Gonmori; Tadashi Maekawa


Japanese Journal of Thrombosis and Hemostasis | 1979

Studies on Antithrombin III (AT III)

Hiroshi Tanaka; Tatsuo Ueno; Hidemi Gonmori; Tokio Takeuchi; Shozo Tanaka; Hitoshi Arai; Norio Kobayashi; Tadashi Maekawa


Japanese Journal of Thrombosis and Hemostasis | 1977

Studies of Normotest (Hepaplastintest) on control of anticoagulant therapy

Tokio Takeuchi; Tatsuo Ueno; Hitoshi Arai; Tadashi Maekawa; Hatsue Tsukada


Japanese Journal of Thrombosis and Hemostasis | 1992

Inhibition of Intravascular Thrombin Generation by Warfarin Administration, with Special Reference to Plasma Thrombin-Antithrombin III Complex (TAT) Levels

Toshimasa Uchiyama; Norio Kanazawa; Toyoshi Sasaki; Sadao Satoh; Toshio Abe; Tokio Takeuchi; Hiroto Sadakata; Norio Kobayashi


Thrombosis and Haemostasis | 1981

Synthesis And Catabolism Of Human Prothrombin And Pivka-II

Hiroyuki Tsukada; Masashi Takada; Hiroshi Tanaka; Tokio Takeuchi; Hidemi Gonmori; N Kobayashi; Tadashi Maekawa


Japanese Journal of Thrombosis and Hemostasis | 1981

Studies of antithrombin III (ATIII)

Hiroshi Tanaka; Masashi Takada; Tatsuo Ueno; Tokio Takeuchi; Shozo Tanaka; Hidemi Gonmori; Norio Kobayashi; Tadashi Maekawa


Japanese Journal of Thrombosis and Hemostasis | 1980

Physicochemical and Biological properties of canine prothrombin and thrombin

Tokio Takeuchi; Masashi Takada; Hiroshi Tanaka; Tatsuo Ueno; Shozo Tanaka; Hidemi Gonmori; Norio Kobayashi; Tadashi Maekawa

Collaboration


Dive into the Tokio Takeuchi's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge